Logo

GenomeDx Biosciences Closes Series A Funding Round

Jan 10, 2012

NEW YORK (GenomeWeb News) – Vancouver-based molecular diagnostics technologies developer GenomeDx Biosciences has closed an undisclosed amount of Series A round of financing.

The company said on Monday that the funding was led by Baird Venture Partners and Aeris Capital AG. The round includes investments from CD Ventures and other individual investors.

Founded in 2007 by Tim Triche, a member of BVP's advisory board, GenomeDx develops and sells molecular diagnostic tests and clinical support tools for personalized medicine applications in clinical cancer care.

Filed under

Diagnostics
Molecular Diagnostics
GenomeDx
Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.